Earnings Feed
Start Free
ARRAY BIOPHARMA INC·4

Aug 17, 4:46 PM ET

VAN LUNSEN GIL J 4

4 · ARRAY BIOPHARMA INC · Filed Aug 17, 2018

Insider Transaction Report

Form 4
Period: 2018-08-15
ARRAY BIOPHARMA INCARRY
VAN LUNSEN GIL J
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2018-08-15$5.60/sh+14,500$81,200→ 40,797 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-08-15−7,000→ 18,000 total
    Exercise: $5.95Exp: 2026-10-27→ Common Stock (7,000 underlying)
  • Exercise/Conversion

    Common Stock

    2018-08-15$5.95/sh+7,000$41,650→ 26,297 total
  • Sale

    Common Stock

    2018-08-15$13.92/sh−21,500$299,280→ 19,297 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2018-08-15−14,500→ 0 total
    Exercise: $5.60Exp: 2023-10-23→ Common Stock (14,500 underlying)
Footnotes (3)
  • [F1]These trades were made pursuant to a Rule 10b5-1 trading plan.
  • [F2]Options vested on October 27, 2017.
  • [F3]Options vested on October 23, 2014.

Documents

2 files